Assertion: amphetamine's use | /r/CapableOf | increase the risk of serotonin syndrome
Facets:
Source sentences:
text: The concomitant use of amphetamine sulfate tablets and CYP2D6 inhibitors may increase the exposure of amphetamine sulfate tablets compared to the use of the drug alone and increase the risk of serotonin syndrome.
text: The concomitant use of amphetamine sulfate tablets and serotonergic drugs increases the risk of serotonin syndrome.
text: The concomitant use of Evekeo and CYP2D6 inhibitors may increase the exposure of Evekeo compared to the use of the drug alone and increase the risk of serotonin syndrome.
text: The concomitant use of Evekeo and serotonergic drugs increases the risk of serotonin syndrome.
text: The concomitant use of Adderall® and CYP2D6 inhibitors may increase the exposure of Adderall® compared to the use of the drug alone and increase the risk of serotonin syndrome.
text: The concomitant use of Adderall® and serotonergic drugs increases the risk of serotonin syndrome.
text: The concomitant use of Dextroamphetamine sulfate tablets and CYP2D6 inhibitors may increase the exposure of Dextroamphetamine sulfate tablets compared to the use of the drug alone and increase the risk of serotonin syndrome.
text: The concomitant use of Dextroamphetamine sulfate tablets and serotonergic drugs increases the risk of serotonin syndrome.
text: The concomitant use of Amphetamine extended-release oral suspension and serotonergic drugs increases the risk of serotonin syndrome.
text: The concomitant use of Methamphetamine hydrochloride tablets and CYP2D6 inhibitors may increase the exposure of Methamphetamine hydrochloride tablets compared to the use of the drug alone and increase the risk of serotonin syndrome.
text: The concomitant use of Methamphetamine hydrochloride tablets and serotonergic drugs increases the risk of serotonin syndrome.
text: The concomitant use of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets and CYP2D6 inhibitors may increase the exposure of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets compared to the use of the drug alone and increase the risk of serotonin syndrome.
text: The concomitant use of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate tablets and serotonergic drugs increases the risk of serotonin syndrome.
text: The concomitant use of Adzenys XR-ODT and serotonergic drugs increases the risk of serotonin syndrome.
text: The concomitant use of Desoxyn and CYP2D6 inhibitors may increase the exposure of Desoxyn compared to the use of the drug alone and increase the risk of serotonin syndrome.
text: The concomitant use of Desoxyn and serotonergic drugs increases the risk of serotonin syndrome.